InvestorsHub Logo
Followers 829
Posts 119614
Boards Moderated 14
Alias Born 09/05/2002

Re: SevenTenEleven post# 144

Tuesday, 11/03/2015 9:25:27 AM

Tuesday, November 03, 2015 9:25:27 AM

Post# of 232
The PCSK9 program is clearly the crown jewel.

Regarding Angiomax, MDCO could continue to generate meaningful sales if it licensed EGRX's ready-to-use formulation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”